Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenPierre D. Delmas, Claus Christiansen, Michael Draper et al.|New England Journal of Medicine|1997Cited by 1.6k
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral DensityRobert R. Recker, Stephen L. Myers, Charles Benson et al.|Journal of Bone and Mineral Research|2014Cited by 291
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fracturesPeyman Hadji, John L. Stock, Bruce Mitlak et al.|Osteoporosis International|2011Cited by 135